| Predicted Trait | |
| Reported Trait | Colorectal cancer |
| Mapped Trait(s) | colorectal cancer (MONDO_0005575) |
| Score Construction | |
| PGS Name | cGRS_Colorectal |
| Development Method | |
| Name | Pruning and Thresholding (P+T) |
| Parameters | GWAS significant and r2 < 0.2. PGS levels were computed as product(dosage*weight/expected risk effect), where the expected risk effect for each variant was calculated based on the risk allele frequence (f) and risk allele weight (OR) as f^2*OR^2 + 2f(1-f)OR + (1-f)^2. |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 30 |
| Effect Weight Type | Odds Ratio over expected risk |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000075 |
| Citation (link to publication) | Shi Z et al. Cancer Med (2019) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 96.8% African: 3.2% 208,379 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST000053 Europe PMC: 17618284 |
1,890 individuals | European | CoRGI |
GWAS Catalog: GCST000169 Europe PMC: 18372905 |
1,849 individuals | European | CoRGI |
GWAS Catalog: GCST000843 Europe PMC: 20972440 |
7,962 individuals | European | NR |
GWAS Catalog: GCST001161 Europe PMC: 21761138 |
6,322 individuals | European | NR |
GWAS Catalog: GCST001544 Europe PMC: 22634755 |
17,780 individuals | European | COGS, CoRGI, NSCCG, SOCCS, VICTOR |
GWAS Catalog: GCST006131 Europe PMC: 29917119 |
6,597 individuals | African American or Afro-Caribbean | NR |
GWAS Catalog: GCST006131 Europe PMC: 29917119 |
67,812 individuals | European | NR |
GWAS Catalog: GCST000168 Europe PMC: 18372901 |
1,983 individuals | European (U.K.) |
NR |
GWAS Catalog: GCST000843 Europe PMC: 20972440 |
30,420 individuals | European | NR |
GWAS Catalog: GCST001787 Europe PMC: 23266556 |
27,809 individuals | European | NR |
GWAS Catalog: GCST003017 Europe PMC: 26151821 |
37,955 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM000474 | PSS000274| European Ancestry| 13,814 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Colorectal cancer | — | — | Mean realative risk: 1.08 [1.04, 1.12] Wilcoxon test (case vs. control) p-value: 8.29e-06 |
— | — |
| PPM000485 | PSS000274| European Ancestry| 13,814 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Colorectal cancer | — | — | Odds Ratio (OR; high vs. average risk groups): 1.18 [0.87, 1.61] | — | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000274 | Primary tumor samples from TCGA | — | [
|
Mean = 68.0 years Sd = 13.0 years |
European | — | TCGA | — |
| PSS000274 | — | — | [
|
— | European | — | eMERGE | — |